Literature DB >> 31729260

Identification and antimicrobial properties of a new alkaloid produced by marine-derived Verrucosispora sp. FIM06-0036.

Ming-Hong Chen1, Yun-Yang Lian1, Dong-Sheng Fang1, Li Chen1, Jia Jia2, Wen-Long Zhang1, Ru Lin1, Yang Xie1, Hong-Kai Bi2, Hong Jiang1.   

Abstract

The actinomycete strain FIM06-0036 was isolated from marine sponge sample collected from the East China Sea and identified as Verrucosispora sp. based upon the results of 16S rRNA sequence analysis. One new alkaloid, 2-ethylhexyl 1H-imidazole-4-carboxylate (1), together with a known alkaloid butyl 1H-imidazole-4-carboxylate (2) was obtained from the fermentation products of this strain, the structures of compounds 1 and 2 were determined by their detailed analysis of 1 D, 2 D NMR and HR-ESI-MS data, along with literature data analysis. Compounds 1 and 2 were evaluated for their antimicrobial activity with MIC (minimum inhibitory concentration) values ranging from 8 to 256 μg · mL-1 against Helicobacter pylori, Klebsiella Pneumonia, Staphylococcus aureus and Enterococcus faecalis.

Entities:  

Keywords:  Actinomycete; Helicobacter pylori; Verrucosispora; antibiotics; antimicrobial activity

Year:  2019        PMID: 31729260     DOI: 10.1080/14786419.2019.1689498

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  3 in total

Review 1.  Natural Products from Actinomycetes Associated with Marine Organisms.

Authors:  Jianing Chen; Lin Xu; Yanrong Zhou; Bingnan Han
Journal:  Mar Drugs       Date:  2021-11-10       Impact factor: 5.118

Review 2.  Marine Actinobacteria a New Source of Antibacterial Metabolites to Treat Acne Vulgaris Disease-A Systematic Literature Review.

Authors:  Maria Clara De La Hoz-Romo; Luis Díaz; Luisa Villamil
Journal:  Antibiotics (Basel)       Date:  2022-07-18

Review 3.  Novel Alkaloids from Marine Actinobacteria: Discovery and Characterization.

Authors:  Anne-Sofie De Rop; Jeltien Rombaut; Thomas Willems; Marilyn De Graeve; Lynn Vanhaecke; Paco Hulpiau; Sofie L De Maeseneire; Maarten L De Mol; Wim K Soetaert
Journal:  Mar Drugs       Date:  2021-12-22       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.